Health Canada
NOTICE
Health Canada implementation of the ICH E6(R3) guideline: Notice to stakeholders
Published: 10/17/2025Detected: 3/22/2026
Summary preview
Introduces the adoption of the ICH E6(R3) guideline for Good Clinical Practice, enhancing the compliance and operational framework for clinical trials in Canada.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountclinical
#Good Clinical Practice
#clinical trials
#ICH guidelines
#risk-based monitoring
#informed consent
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/2/2026
- Advisory Committee: National Pharmacare Committee of Experts10/2/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/2/2026
- Advisory Committee: Expert Task Force on Substance Use10/2/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/2/2026